HealthStream Inc
SWB:HL5

Watchlist Manager
HealthStream Inc Logo
HealthStream Inc
SWB:HL5
Watchlist
Price: 24.4 EUR 0.83%
Market Cap: €739.1m

Wall St Price Targets

HL5 Price Targets Summary
HealthStream Inc

Wall Street analysts forecast HL5 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HL5 is 30.16 EUR with a low forecast of 25.1 EUR and a high forecast of 36 EUR.

Lowest Forecast
Price Target
25.1 EUR
3% Upside
Average Forecast
Price Target
30.16 EUR
24% Upside
Highest Forecast
Price Target
36 EUR
48% Upside
HealthStream Inc Competitors:
Price Targets
TMP
Tompkins Financial Corp
12% Upside
CIM
Chimera Investment Corp
28% Upside
BBW
Build-A-Bear Workshop Inc
106% Upside

Revenue
Forecast

9% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 7 years is 5%.

Gross Profit
Forecast

9% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
9% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 2 years is 8%.

Operating Income
Forecast

3% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
3% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 7 years is 13%.

Pre-Tax Income
Forecast

4% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
4% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 2 years is 24%.

Net Income
Forecast

7% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
7% / Year
Past Growth
17% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 2 years is 17%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is HL5's stock price target?
Price Target
30.16 EUR

According to Wall Street analysts, the average 1-year price target for HL5 is 30.16 EUR with a low forecast of 25.1 EUR and a high forecast of 36 EUR.

What is the Revenue forecast for HealthStream Inc?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 7 years is 5%.

What is the Gross Profit forecast for HealthStream Inc?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 2 years is 8%.

What is the Operating Income forecast for HealthStream Inc?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 7 years is 13%.

What is the Pre-Tax Income forecast for HealthStream Inc?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 2 years is 24%.

What is the Net Income forecast for HealthStream Inc?
Projected CAGR
17%

Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 2 years is 17%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett